TFF PharmaceuticalsTFFP
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 23 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings, up 2 from Q2 2024. 3 opened new positions and 1 sold out. The largest holders were Carlson Capital, L.P. ($590K), Armistice Capital, LLC ($458K) and Westside Investment Management, Inc. ($151K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $29K |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 93,584 shares bought and 3,400 shares sold, net +90,184 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Carlson Capital, L.P. | 0.36% | No change | 293,460 | $590K |
| Armistice Capital, LLC | 0.01% | Add +22.8% | 228,000 | $458K |
| Westside Investment Management, Inc. | 0.03% | Add +49.1% | 75,264 | $151K |
| DRW Securities, LLC | 0.00% | No change | 40,000 | $80K |
| Geode Capital Management, LLC | 0.00% | Add +28.4% | 27,999 | $56K |
| Renaissance Technologies | 0.00% | Add +38.7% | 20,497 | $41K |
| Citadel Advisors | 0.00% | New | 13,579 | $27K |
| Vanguard Group Inc. | 0.00% | No change | 12,136 | $24K |
| Nwam LLC | 0.00% | No change | 10,240 | $21K |
| BlackRock, Inc. | 0.00% | — | 7,186 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -60.5% | 1,948 | $4K |
| Nordwand Advisors, LLC | 0.00% | New | 1,000 | $2K |
| University of Texas/Texas Am Investment Management Co. | 0.00% | No change | 882 | $2K |
| UBS Group AG | 0.00% | Reduce -8.2% | 675 | $1K |
| ORG Partners LLC | 0.00% | Reduce -27.0% | 540 | $1K |
| Gen-Wealth Partners Inc | 0.00% | No change | 100 | $251 |
| Raleigh Capital Management Inc. | 0.00% | No change | 91 | $183 |
| Wells Fargo & Company | 0.00% | No change | 61 | $123 |
| HM Payson & Co. | 0.00% | No change | 60 | $121 |
| Osaic Holdings, Inc. | 0.00% | No change | 40 | $80 |
| Morgan Stanley | 0.00% | No change | 32 | $64 |
| Bank of America Corp. | 0.00% | Add +21.7% | 28 | $56 |
| Danske Bank A/S | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.